Skip to main content

Table 1 Demographic and clinical characteristics of phenotypes

From: The role of clinical phenotypes in decisions to limit life-sustaining treatment for very old patients in the ICU

Variable

Phenotype

p-value

A-very low SOFA

B-respirat. failure

C-oldest old

D-moderate SOFA

E-renal failure

F-geriatric, low SOFA

G-geriatric, high SOFA

Number of patients

244

247

134

252

143

106

142

 

Age-median (IQR)

83 (81–85)

83 (81–85)

92 (90–94)

83 (81–85)

83 (81–85)

84 (82–86)

85 (83–89)

 < 0.001

Gender-number (% female)

123 (50%)

116 (47%)

83 (61%)

91 (36%)

45 (31%)

68 (64%)

74 (52%)

 < 0.001

Admission reason-number (%)

        

 Respiratory/cardiovascular

58 (23%)

187 (75%)

80 (59%)

119 (47%)

61 (42%)

63 (59%)

73 (51%)

 < 0.001

 Sepsis

8 (3%)

16 (6%)

5 (3%)

39 (15%)

26 (18%)

9 (8%)

42 (29%)

 < 0.001

 Emergency surgery

51 (20%)

20 (8%)

21 (15%)

56 (22%)

11 (7%)

11 (10%)

14 (9%)

 < 0.001

SOFA score-median (IQR)

1 (0–2)

4 (3–4)

4 (2–5)

7 (7–9)

6 (5–8)

3 (2–4)

11 (10–12)

 < 0.001

Geriatric featuresa median (IQR)

        

 CFS

3 (2–3)

4 (3–4)

4 (3–5)

3 (2–4)

4 (3–4)

6 (6–7)

7 (6–7)

 < 0.001

 Katz score

6 (6–6)

6 (6–6)

5 (4–6)

6 (6–6)

6 (5–6)

3 (2–4)

1 (0–2)

 < 0.001

 IQCODE

3.1 (3–3.2)

3.1 (3–3.3)

3.4 (3.1–3.9)

3.1 (3–3.3)

3.2 (3–3.4)

3.7 (3.2–4)

4.7 (4.1–5)

 < 0.001

 CPS

7 (5–10)

12 (9–14)

9 (6–12)

9 (6–12)

12 (9–16)

16 (14–20)

11 (8–14)

 < 0.001

Interventions-number (%)

        

 Invasive ventilation

38 (15%)

88 (35%)

32 (23%)

191 (75%)

33 (23%)

24 (22%)

121 (85%)

 < 0.001

 Vasopressors

50 (20%)

66 (26%)

54 (40%)

249 (98%)

74 (51%)

39 (36%)

136 (95%)

 < 0.001

 Renal replacement therapy

4 (1%)

4 (1%)

0

27 (10%)

62 (43%)

5 (4%)

26 (18%)

 < 0.001

Limitations of LST-number (%)

        

 LST withheld

26 (10%)

59 (23%)

53 (39%)

68 (27%)

32 (22%)

40 (37%)

58 (40%)

 < 0.001

 LST withdrawn

5 (2%)

25 (10%)

7 (5%)

31 (12%)

10 (7%)

9 (8%)

16 (11%)

 < 0.001

 LST withheld and withdrawn

3 (1%)

15 (6%)

5 (3%)

22 (8%)

9 (6%)

6 (5%)

12 (8%)

0.003

Length of stay in ICU (days)-median (IQR)

2.4 (1.1–4)

5 (2.2–8.5)

3 (1.1–5)

6 (3–12)

5 (2.7–7.9)

3 (1.9–6)

6 (2.5–13)

 < 0.001

Died in ICU-number (%)

        

 All

12 (5%)

30 (12%)

18 (13%)

51 (20%)

22 (15%)

10 (9%)

81 (57%)

 < 0.001

 After LST withheld

6 (23%)

17 (29%)

13 (25%)

27 (40%)

13 (41%)

5 (13%)

35 (60%)

 < 0.001

 (p valueb)

(0.004)

(0.017)

(0.031)

(0.29)

(0.067)

(1.0)

(0.58)

 

Died within 30 days-number (%)

        

 All

21 (9%)

52 (21%)

42 (31%)

74 (29%)

33 (23%)

25 (24%)

96 (68%)

 < 0.001

 After LST withheld

11 (42%)

25 (42%)

27 (51%)

39 (57%)

19 (59%)

13 (32%)

44 (76%)

 < 0.001

 (p valueb)

(< 0.001)

(0.004)

(< 0.001)

(0.003)

(< 0.001)

(0.13)

(0.13)

  1. aCFS—clinical frailty scale, Katz score to assess functional ability by activities of daily living, IQCODE—informant questionnaire on cognitive decline in the elderly, CPS—comorbidity and polypharmacy score
  2. Bfor comparison with patients without limitations of LST